BLACKTHORN THERAPEUTICS
BlackThorn Therapeutics operator of a clinical-stage biopharmaceutical company intended to develop precision medicine for disorders of the central nervous system (CNS) based on advances in computational and clinical neuroscience. The company leverages a deep understanding of brain and behavior relationships that seeks to overcome historic challenges in drug discovery and development by targeting dysfunctional brain circuits. Its proprietary computational platform, the company seeks to identify novel targets, small molecule drug candidates and biologically-based patient subgroups most likely to respond to treatment.
BLACKTHORN THERAPEUTICS
Industry:
Artificial Intelligence Biotechnology Health Care Therapeutics
Founded:
2015-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.blackthornrx.com
Total Employee:
11+
Status:
Closed
Total Funding:
138 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Domain Not Resolving Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
Homerun Smart
Homerun Smart is an independent research and development enterprise dedicated to artificial intelligence.
Current Advisors List
Board_member
Board_member
Board_observer
Board_member
Board_member
Current Employees Featured
Paul L Berns Executive Chair @ BlackThorn Therapeutics
Executive Chair
Thomas Z. Lauritzen Head of Data Science @ BlackThorn Therapeutics
Head of Data Science
Annette Madrid CMO @ BlackThorn Therapeutics
CMO
2016-01-01
Tanya Wallace Vice President of Biology @ BlackThorn Therapeutics
Vice President of Biology
Rezi Zawadzki VP of Biometric @ BlackThorn Therapeutics
VP of Biometric
Ed Roberts Co-Founder and Consultant @ BlackThorn Therapeutics
Co-Founder and Consultant
2012-01-01
Lori Jean Van Orden VP of Preclinical Sciences @ BlackThorn Therapeutics
VP of Preclinical Sciences
Founder
Investors List
GV
GV investment in Series B - BlackThorn Therapeutics
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series B - BlackThorn Therapeutics
The Scripps Research Institute
The Scripps Research Institute investment in Series B - BlackThorn Therapeutics
Premier Partners
Premier Partners investment in Series B - BlackThorn Therapeutics
Vertex Ventures HC
Vertex Ventures HC investment in Series B - BlackThorn Therapeutics
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series B - BlackThorn Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - BlackThorn Therapeutics
Biomatics Capital Partners
Biomatics Capital Partners investment in Series B - BlackThorn Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - BlackThorn Therapeutics
Mercury
Mercury investment in Series B - BlackThorn Therapeutics
Official Site Inspections
http://www.blackthornrx.com
- Host name: 201.23.196.104.bc.googleusercontent.com
- IP address: 104.196.23.201
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "BlackThorn Therapeutics"
BlackThorn Therapeutics - Crunchbase Company …
BlackThorn Therapeutics is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence.See details»
Blackthorn Therapeutics 2025 Company Profile: Valuation
Information on acquisition, funding, cap tables, investors, and executives for Blackthorn Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
BlackThorn Therapeutics Information - RocketReach
Our clinical pipeline is designed to restore balance to dysregulated brain circuits and empower individuals with CNS disorders to live better lives. BlackThorn is headquartered in San …See details»
BlackThorn Therapeutics - VentureRadar
"BlackThorn Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of people with neurobehavioral disorders through the discovery and …See details»
BlackThorn Therapeutics | Companies | RadialReport
Clinical-stage neurobehavioral health companyAbout Blackthorn Therapeutics BlackThorn Therapeutics operates as a clinical-stage neurobehavioral health company. It develops …See details»
BlackThorn Therapeutics, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BlackThorn Therapeutics, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
BlackThorn Therapeutics - Company info. interviews, news
BlackThorn Therapeutics, Inc., is a clinical-stage neurobehavioral health company pioneering the next generation of artificial intelligence technologies to advance its pipeline of targeted …See details»
Blackthorn Therapeutics (USA) Funding: $138M
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company that uses a novel and robust platform (INFORM™) to link behavioral deficits with brain physiology to discover and …See details»
BlackThorn Therapeutics Company Profile: , Investments, Contact ...
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted medicines for the treatment of central nervous system (CNS) …See details»
BlackThorn Therapeutics: Revenue, Worth, Valuation
About BlackThorn Therapeutics BlackThorn Therapeutics is a Biotech related company founded in 2016 and based in San Francisco with an estimated revenue of $155K, and 2 employees. It …See details»
BlackThorn Therapeutics - Craft
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company that uses a novel and robust platform (INFORM™) to link behavioral deficits with brain physiology to discover and …See details»
BlackThorn Therapeutics Company Information - Funding, …
BlackThorn Therapeutics A biopharmaceutical company developing neurobehavioural therapeutic treatments using artificial intelligence and clinical neuroscience.See details»
BlackThorn bags $76M to push targeted treatments for brain …
Jun 13, 2019 BlackThorn Therapeutics raised $76 million to push at least one of its targeted treatments for neurobehavioral disorders into phase 2 trials and to keep working on the …See details»
BlackThorn Therapeutics | VentureRadar
BlackThorn Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of people with neurobehavioral disorders through the discovery and development of …See details»
BlackThorn - Biomatics Capital
Jan 4, 2019 BlackThorn Therapeutics Reports Data Supporting Phase 2 Development of KOR Antagonist, BTRX-335140, in Depression and Other CNS Disorders Dec 11, 2019See details»
BlackThorn Therapeutics | Companies | Mindmaps
Clinical-stage neurobehavioral health companyAbout Blackthorn Therapeutics BlackThorn Therapeutics operates as a clinical-stage neurobehavioral health company. It develops …See details»
BlackThorn Therapeutics Company Overview, Contact Details
Jun 13, 2019 Blackthornrx promoted Bill Martin to president and chief operating officer on Nov 2nd '18. BlackThorn Therapeutics, a clinical-stage biopharmaceutical company discovering …See details»
BlackThorn Therapeutics - Wiki | Golden
BlackThorn Therapeutics is a biopharmaceutical company developing neurobehavioural therapeutic treatments using artificial intelligence and clinical neuroscience that is …See details»
BlackThorn Therapeutics Announces R&D Updates - Business Wire
Jan 4, 2019 BlackThorn Therapeutics, a computational sciences and therapeutics company with a focus on neurobehavioral disorders, today announced key Research &amSee details»
BlackThorn Therapeutics Announces Positive Phase 1 Results for …
Apr 1, 2019 — Phase 1 results and new translational data supporting the development of BTRX-335140 for neurobehavioral disorders presented at the Kappa Therapeutics 2019 Conference —See details»